Neuroimmune mechanisms of opioid-mediated conditioned immunomodulation.
about
Intensive Care Unit-acquired infection as a side effect of sedationWhole-genome expression profile in zebrafish embryos after chronic exposure to morphine: identification of new genes associated with neuronal function and mu opioid receptor expression.Effects of fentanyl anesthesia and sufentanil anesthesia on regulatory T cells frequenciesEarly-life experience decreases drug-induced reinstatement of morphine CPP in adulthood via microglial-specific epigenetic programming of anti-inflammatory IL-10 expression.Effect of κ-opioid receptor agonist on the growth of non-small cell lung cancer (NSCLC) cellsVentral tegmental area-basolateral amygdala-nucleus accumbens shell neurocircuitry controls the expression of heroin-conditioned immunomodulation.Effect of chronic delivery of the Toll-like receptor 4 antagonist (+)-naltrexone on incubation of heroin craving.Effects of neonatal stress and morphine on kappa opioid receptor signalingAssessment of individual differences in the rat nucleus accumbens transcriptome following taste-heroin extended access.Region-specific contribution of the ventral tegmental area to heroin-induced conditioned immunomodulation.Endogenous μ-opioid peptides modulate immune response towards malignant melanoma.Interleukin-1 signaling in the basolateral amygdala is necessary for heroin-conditioned immunosuppression.Effects of neonatal stress and morphine on murine hippocampal gene expressionCCR5 mediates HIV-1 Tat-induced neuroinflammation and influences morphine tolerance, dependence, and reward.Morphology of subcortical brain nuclei is associated with autonomic function in healthy humans.
P2860
Q33919036-ECD06711-7495-48B2-85ED-C47A97E1F1E7Q34363541-E1F27438-5C6D-4E75-9754-848E5385BB89Q34733248-BA2199A9-24D4-497A-B8C0-19E5C3A0D79FQ35676825-483A8275-0498-4EA4-8334-99D990DECB9DQ35832263-7C57EF1C-C20D-4481-9C6D-47EBEBC9138BQ36620596-58FA6B0E-AC6F-4A42-BCF6-0AABE50D536BQ36736335-D263DDE8-9E31-4EFA-94B5-39E144753A25Q36948685-52FAEA0F-8A24-45E6-9D66-5DE2D52BD837Q36971189-721854D4-3BAD-486E-AF59-D5D6862EFFA7Q37707087-A8C03666-ED78-4E1B-AC1E-61847EF81FD0Q39826592-2DAFDE26-4E48-438B-8B78-63F979DDC102Q40354737-C7D31006-6E92-49D5-AB0E-A954B3CBD2C8Q42725528-0B9F4708-D3F6-4630-A6A4-D7C274BFD8B1Q45073147-89311A8E-0420-4307-8A0E-44E0032ACB4BQ47596137-EA49D8FD-0466-46E5-AC1D-A371D10CA853
P2860
Neuroimmune mechanisms of opioid-mediated conditioned immunomodulation.
description
2007 nî lūn-bûn
@nan
2007 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Neuroimmune mechanisms of opioid-mediated conditioned immunomodulation.
@ast
Neuroimmune mechanisms of opioid-mediated conditioned immunomodulation.
@en
type
label
Neuroimmune mechanisms of opioid-mediated conditioned immunomodulation.
@ast
Neuroimmune mechanisms of opioid-mediated conditioned immunomodulation.
@en
prefLabel
Neuroimmune mechanisms of opioid-mediated conditioned immunomodulation.
@ast
Neuroimmune mechanisms of opioid-mediated conditioned immunomodulation.
@en
P2093
P2860
P1476
Neuroimmune mechanisms of opioid-mediated conditioned immunomodulation.
@en
P2093
Donald T Lysle
Kelly A Carrigan
Stephanie G Ijames
Timothy B Saurer
P2860
P356
10.1016/J.BBI.2007.06.009
P577
2007-08-03T00:00:00Z